Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Gastroenterología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 1/2 Open-label, Multicentre, Dose Escalation and Expansion Study to Investigate the Safety, Tolerability, and Clinical Activity of Belantamab as Monotherapy and in Combination With Other Treatments in Participants With Multiple Myeloma
INTERVENTIONAL
Inicio: 14 de jun de 2023
ID: NCT05714839
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease
INTERVENTIONAL
Inicio: 9 de abr de 2018
ID: NCT03105102
Completado
Fase 3
ClinicalTrials.gov
A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
INTERVENTIONAL
Inicio: 1 de feb de 2008
ID: NCT00658528
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study, With a Vedolizumab IV Reference Arm, to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
INTERVENTIONAL
Inicio: 18 de dic de 2015
ID: NCT02611830
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Global, Multi-Center, Double-Blind, Randomized, Efficacy Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
INTERVENTIONAL
Inicio: 28 de nov de 2018
ID: NCT03653507
Completado
Fase 3
ClinicalTrials.gov
A Randomised Multi-Centre, Double-Blind, Double-Dummy, Two Way Cross-Over, Twelve Weeks Non-inferiority Study to Evaluate The Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol 250/50 mcg Twice Daily Delivered Through a Capsule-Based Inhaler and a Multi-Dose Inhaler for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 14 de nov de 2013
ID: NCT01978145
Completado
Fase 3
ClinicalTrials.gov
A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine
INTERVENTIONAL
Inicio: 1 de sept de 2004
ID: NCT00099294
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
INTERVENTIONAL
Inicio: 10 de nov de 2023
ID: NCT06161571
Desconocido
Fase 1
ClinicalTrials.gov
Biliary Tissue Sampling Using a Cytology Brush or the G.I.U.M. Catheter: a Prospective Randomized Controlled Study.
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00160836
Completado
ClinicalTrials.gov
A Modified Case Control Study to Identify Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate
OBSERVATIONAL
Inicio: 1 de may de 2009
ID: NCT00890448
Reclutando
ClinicalTrials.gov
Argentine Registry of Crohn's Disease and Ulcerative Colitis
OBSERVATIONAL
Inicio: 14 de jul de 2023
ID: NCT07155148
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
INTERVENTIONAL
Inicio: 19 de sept de 2022
ID: NCT05242484
Reclutando
ClinicalTrials.gov
Argentinean Registry on the Management of Helicobacter Pylori Infection
OBSERVATIONAL
Inicio: 17 de may de 2021
ID: NCT06579365
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Active-controlled, Double-blind, Double-dummy, Parallel Group Design, Multi-center Trial to Compare the Efficacy and Safety of 2.5 µg and 5 µg Tiotropium Inhalation Solution Delivered by the Respimat Inhaler With Tiotropium Inhalation Capsules 18 µg Delivered by the HandiHaler (TIOSPIR)
INTERVENTIONAL
Inicio: 1 de may de 2010
ID: NCT01126437
Activo, no recluta
Fase 3
ClinicalTrials.gov
The Effect of Semaglutide in Subjects With Non-cirrhotic Non-alcoholic Steatohepatitis
INTERVENTIONAL
Inicio: 1 de abr de 2021
ID: NCT04822181
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
INTERVENTIONAL
Inicio: 13 de mar de 2024
ID: NCT06318169
Completado
Fase 3
ClinicalTrials.gov
A 76-week Prospective, Open-label, Multicenter Study to Evaluate the Long-term Effect of Rivastigmine Capsule and Transdermal Patch on Worsening of the Underlying Motor Symptoms of PD in Patients With Mild to Moderately Severe Dementia Associated With Parkinson's Disease (PDD)
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00623103
Completado
Fase 3
ClinicalTrials.gov
A 24-Week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components Delivered Once Daily (AM) Via a Novel Dry Powder Inhaler Compared With Placebo in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 19 de oct de 2009
ID: NCT01054885
Reclutando
ClinicalTrials.gov
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure (ACLF): iNdications and outComEs
OBSERVATIONAL
Inicio: 8 de jul de 2021
ID: NCT04613921
Completado
Fase 2
ClinicalTrials.gov
Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Concomitant Systemic Oxaliplatin, Fluorouracil and Leucovorin Chemotherapy, and Anti-Angiogenic Therapy
INTERVENTIONAL
Inicio: 1 de jun de 2009
ID: NCT00932438
Anterior
1
...
20
21
22
...
434
Siguiente
Filtros